SAXENDA PEN

SAXENDA PEN

Saxenda, with liraglutide as its active ingredient, offers a medical approach to weight management for adults with obesity or those who are overweight with related health conditions. It is also suitable for adolescents aged 12-17 with significant obesity. By aiding initial weight loss and supporting weight maintenance, Saxenda works best when combined with a balanced diet and regular exercise.

This unique injectable solution provides targeted, precise action through subcutaneous administration. It can be conveniently self-injected into the thigh, upper arm, or abdomen, as guided by a healthcare professional, enhancing ease of use and comfort.

3ml x 1 pen

Gradual Dose Escalation for Optimal Use:
To reduce the potential for gastrointestinal symptoms and ensure a comfortable adaptation to Saxenda, it is important to follow a gradual dose escalation schedule:

• Week 1: Begin with a 0.6 mg subcutaneous injection once daily, allowing your body to adjust gradually.
• Week 2: Increase the dosage to 1.2 mg once daily, carefully monitoring your body's response.
• Week 3: Further raise the dosage to 1.8 mg, continuing daily subcutaneous administration.
• Week 4: Progress to 2.4 mg per day, paying attention to your body's adaptability.
• Week 5 and Beyond: Maintain the full daily dosage of 3 mg via subcutaneous injection for consistent weight management support.

By following this step-by-step regimen, Saxenda offers a comfortable and effective path to achieving and maintaining a healthier weight.